First Time Loading...

Amgen Inc
NASDAQ:AMGN

Watchlist Manager
Amgen Inc Logo
Amgen Inc
NASDAQ:AMGN
Watchlist
Price: 304.72 USD -0.1% Market Closed
Updated: Jun 11, 2024

Amgen Inc
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amgen Inc
Net Change in Cash Peer Comparison

Comparables:
ABBV
GILD
MRNA
VRTX
REGN

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Amgen Inc
NASDAQ:AMGN
Net Change in Cash
-$21.9B
CAGR 3-Years
-140%
CAGR 5-Years
-56%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Change in Cash
$11.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
26%
Gilead Sciences Inc
NASDAQ:GILD
Net Change in Cash
-$218m
CAGR 3-Years
67%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Moderna Inc
NASDAQ:MRNA
Net Change in Cash
-$1.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Change in Cash
-$126.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Change in Cash
-$1.3B
CAGR 3-Years
-20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Amgen Inc's Net Change in Cash?
Net Change in Cash
-21.9B USD

Based on the financial report for Mar 31, 2024, Amgen Inc's Net Change in Cash amounts to -21.9B USD.

What is Amgen Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
-56%

The average annual Net Change in Cash growth rates for Amgen Inc have been -140% over the past three years , -56% over the past five years .